-weighted patent-intensity as a proxy for R&D output; the stock of citation-weighted patents as a proxy for the accumulated stock of …

-weighted patent-intensity as a proxy for R&D output; the stock of citation-weighted patents as a proxy for the accumulated stock of …

The purpose of this study is to present a unique database on commercialized patents and to illustrate how it can be … used to analyze the commercialization process of patents. The dataset is based on a survey of Swedish patents owned by … commercialization not found anywhere else, including whether, when and how (acquisition, licensing, existing or new firm) patents were …

The purpose of this study is to present a unique database on commercialized patents and to illustrate how it can be … used to analyze the commercialization process of patents. The dataset is based on a survey of Swedish patents owned by … commercialization not found anywhere else, including whether, when and how (acquisition, licensing, existing or new firm) patents were …

The purpose of this study is to present a unique database on commercialized patents and to illustrate how it can be … used to analyze the commercialization process of patents. The dataset is based on a survey of Swedish patents owned by … commercialization not found anywhere else, including whether, when and how (acquisition, licensing, existing or new firm) patents were …

venture capital (VC) financing. We argue that investors are faced with considerable uncertainty and therefore rely on patents … British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate … attention to patent quality, financing those ventures faster which later turn out to have high-quality patents. Patent …

venture capital (VC) financing. We argue that investors are faced with considerable uncer-tainty and therefore rely on patents … British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate … attention to patent quality, financing those ventures faster which later turn out to have high-quality patents. Patent …

venture capital (VC) financing. We argue that investors are faced with considerable uncer-tainty and therefore rely on patents … British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate … attention to patent quality, financing those ventures faster which later turn out to have high-quality patents. Patent …

venture capital (VC) financing. We argue that investors are faced with considerable uncertainty and therefore rely on patents … British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate … attention to patent quality, financing those ventures faster which later turn out to have high-quality patents. Patent …